Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Recurrent corneal erosions; and sometimes findings: Reduced visual acuity. 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Recurrent corneal erosions, Map-dot-fingerprint corneal dystrophy, Clouding of the cornea (corneal dystrophy) |
Arms and legs | 1 | Map-dot-fingerprint corneal dystrophy |
TGFBI function has not been fully characterized.
Epithelial basement membrane dystrophy is associated with mutations in the TGFBI gene on chromosome 5.
Genetic testing for TGFBI is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for epithelial basement membrane dystrophy has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
1 clinical trial registered. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
19 publications have been identified in PubMed for epithelial basement membrane dystrophy. Research spans Clinical Trial Publication (42%), Case Report / Case Series (21%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 8 | 42% |
Patient case studies | 4 | 21% |
Disease patterns and progression | 3 | 16% |
Testing and diagnosis research | 2 | 11% |
Research summaries | 1 | 5% |
Laboratory research | 1 | 5% |
Zengin S (2026). [PMID: 41726249](https://pubmed.ncbi.nlm.nih.gov/41726249/). *Case reports in pathology*. [Case Report / Case Series]
Charoenrook V (2026). [PMID: 41683752](https://pubmed.ncbi.nlm.nih.gov/41683752/). *International journal of molecular sciences*. [Clinical Trial Publication]
Sneyers A (2026). [PMID: 40974359](https://pubmed.ncbi.nlm.nih.gov/40974359/). *Ophthalmology*. [Clinical Trial Publication]
Kaiser KP (2026). [PMID: 41499048](https://pubmed.ncbi.nlm.nih.gov/41499048/). *International ophthalmology*. [Case Report / Case Series]
Ünal S (2026). [PMID: 41705817](https://pubmed.ncbi.nlm.nih.gov/41705817/). *Turkish journal of ophthalmology*. [Basic Science / Preclinical]
Kimmell SW (2026). [PMID: 41847240](https://pubmed.ncbi.nlm.nih.gov/41847240/). *Clin Optom (Auckl)*. [Clinical Trial Publication]
Paoletti T (2026). [PMID: 41949920](https://pubmed.ncbi.nlm.nih.gov/41949920/). *Cornea*. [Epidemiology / Natural History]
Liskova P (2025). [PMID: 40079222](https://pubmed.ncbi.nlm.nih.gov/40079222/). *Clinical & experimental ophthalmology*. [Review / Meta-Analysis]
Helm S (2025). [PMID: 41497725](https://pubmed.ncbi.nlm.nih.gov/41497725/). *Journal of ophthalmology*. [Clinical Trial Publication]
Touirssa O (2025). [PMID: 40874967](https://pubmed.ncbi.nlm.nih.gov/40874967/). *Journal of epidemiology and global health*. [Epidemiology / Natural History]
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 6:03 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center